Current practices in generation of small
โ
Robert A. Goodnow Jr.
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 113 KB
The current drug discovery processes in many pharmaceutical companies require large and growing collections of high quality lead structures for use in high throughput screening assays. Collections of small molecules with diverse structures and ``drug-like'' properties have, in the past, been acquire